Company
Qpex Biopharma
Rapidly spreading pathogens are a global risk. We are addressing these health threats by building a pipeline of novel therapies.
- Status
- Acquiredas of 2026-09-23Source (opens in a new tab)
- Business model
- B2B
- Legal name
- Qpex Biopharma, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Qpex Biopharma is a clinical-stage biopharmaceutical company developing novel anti-infective therapies. Acquired by Shionogi 2023
Funding snapshot
- Total raised
- $27.4MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $27.4M2018-10-02
Funding rounds
- Round, 2018
- $27.4M2018-10-02, SEC form D sold, 11 investors
About the company
- Status notes
- Acquired by Shionogi 2023
Exit
- Acquisition
- 2023
Loading relationship preview